Richard Alsop

Richard Alsop


Richard focuses on capital markets transactions, corporate governance, corporate finance transactions, financial institutions and underwriting.

Richard advises corporations and investment banks on a broad variety of capital markets work, including IPOs, convertible bonds and investment grade and high-yield bond transactions. He is a contributor and editor for the firm’s annual Corporate Governance Survey.

From 2003 through 2008, Richard was Senior Vice President and General Counsel, Corporate Law at Merrill Lynch & Co., Inc., where he advised executive management and the board of directors on major corporate transactions, corporate finance, corporate governance, executive compensation and other matters. From 1994 through 2003, he held other senior roles in the legal department of Merrill Lynch, including Equity Capital Markets Counsel, Investment Banking General Counsel and Debt Markets General Counsel.

He rejoined the firm in 2010.


Representative matters

The Dow Chemical Company in its inaugural green bond offering of $600 million 5.150% notes due 2034 and $650 million 5.600% notes due 2054.

The underwriters in a $1.45 billion offering consisting of $700 million 5.200% Series US-9 Notes due 2034 and $750 million 5.550% Series US-10 Notes due 2054 by Bell Canada.

Boston Scientific Corporation in its €2 billion registered bond offering by American Medical Systems Europe B.V., it’s wholly owned finance subsidiary, to finance the acquisition of Axonics, Inc.

The Chefs’ Warehouse, Inc. in its $287.5 million Rule 144A offering of 2.375% convertible senior notes due 2028 and related exchanges of outstanding convertible notes.

Ardagh Group S.A. in its registered exchange offer of shares of Ardagh Metal Packaging S.A. for all outstanding Class A Common Shares of Ardagh Group S.A.

Ardagh Metal Packaging S.A. in the merger and deSPAC transaction with Gores Holdings V, Inc.

SAP SE and Qualtrics International Inc. in the carve out of Qualtrics from SAP, consisting of Qualtrics’ IPO, raising $1.55 billion.

The Dow Chemical Company in its $2 billion offering of 2.100% notes due 2030 and 3.600% notes due 2050, as well as the related tender offer for outstanding notes.

American Axle & Manufacturing Inc. in its $600 million offering of 5.00% Senior Notes due 2029.

Boston Scientific Corporation in concurrent offerings of common stock and 5.50% mandatory convertible preferred stock.

The initial purchasers in a $1 billion Rule 144A offering of 4.250% convertible senior notes due 2023 by Royal Caribbean Cruises Ltd.

Altice USA, Inc. in its spin off from Altice Europe N.V.

Altice USA, Inc. in its initial public offering of Class A common stock.

Ardagh Group S.A. in its initial public offering of Class A common shares.

The Dow Chemical Company in its split-off of the Dow Chlorine Products Business and the related debt-for-debt exchange.

ADS Waste Holdings, Inc. in its initial public offering of common stock.

Pro bono

Board Member, Volunteer Lawyers for the Arts

Published Work

Alsop, R. (2024) “The Evolution of Board Effectiveness”, Directors and Boards



New Jersey, 1987
New York, 1988


A.B., cum laude, Columbia University, 1984 J.D., Columbia University, 1987
Harlan Fiske Stone Scholar

A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.